Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Chief Administrative Officer sold 259 shares at $22.73 ($5,887)
  2. 4 Open-market sale Chief Financial Officer sold 443 shares at $22.73 ($10,069)
  3. 4 Open-market sale President, R&D sold 976 shares at $22.73 ($22,184)
  4. 4 Open-market sale Chief Legal Officer sold 294 shares at $22.73 ($6,683)
  5. 4 Open-market sale President and CEO sold 42,000 shares at an average $24.24 ($1,018,080)
  6. 4 Open-market sale Director sold 25,000 shares at $29.95 ($748,750)
  7. 4 Open-market sale Chief Financial Officer sold 26,257 shares at $30.00 ($787,710)
  8. 4 Open-market sale President, R&D sold 25,000 shares at $30.00 ($750,000)
  9. 4 Open-market sale President, R&D sold 4,900 shares at $25.46 ($124,754)
  10. 4 Open-market sale President, R&D sold 8,100 shares at $23.07 ($186,867)
  11. 4 Open-market sale President, R&D sold 15,000 shares at $25.00 ($375,000)
  12. 4 Open-market sale President, R&D sold 8,000 shares at $20.00 ($160,000)
  13. 4 Open-market sale Chief Administrative Officer sold 452 shares at $21.27 ($9,614)
  14. 4 Open-market sale Chief Financial Officer sold 734 shares at $21.26 ($15,605)
  15. 4 Open-market sale President, R&D sold 1,835 shares at $21.27 ($39,030)
  16. 4 Open-market sale Chief Legal Officer sold 734 shares at $21.27 ($15,612)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award President and CEO acquired 814 shares (grant or award)
  20. 4 Open-market sale President, R&D sold 8,000 shares at $20.00 ($160,000)

Page 11 of 16 · 320 filings